CURE Epilepsy
Overview
CURE Epilepsy is a non-profit organization that funds patient-focused research to find a cure for epilepsy by awarding grants to researchers and biotechnology companies.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Quiver Bioscience | Jul 2025 | Grant | Co-investor |
| Neumirna Therapeutics | Jun 2024 | Grant | Co-investor |
| Axonis Therapeutics | Sep 2024 | Grant | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is CURE Epilepsy based?
CURE Epilepsy is headquartered in Chicago, Illinois, United States.
When was CURE Epilepsy founded?
CURE Epilepsy was founded in 1998.
How many portfolio companies does CURE Epilepsy have?
CURE Epilepsy has 3 portfolio companies in Caplight's dataset.
What are some companies in CURE Epilepsy's portfolio?
Portfolio companies visible on Caplight include Quiver Bioscience, Neumirna Therapeutics, Axonis Therapeutics.
What was CURE Epilepsy's most recent investment shown here?
CURE Epilepsy's most recent investment in this portfolio sample was in Quiver Bioscience in 2025.
What sectors does CURE Epilepsy focus on?
CURE Epilepsy focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, AI, Data & Cloud Infrastructure.
What company stages does CURE Epilepsy focus on?
Stage focus information for CURE Epilepsy is not publicly available.